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The protective eﬀect of KIOM-4, a mixture of plant extracts, was examined against streptozotocin (STZ)-induced mitochondrial
oxidative stress in rat pancreatic β-cells (RINm5F). KIOM-4 scavenged superoxide and hydroxyl radicals generated by
xanthine/xanthine oxidase and Fenton reaction (FeSO4/H2O2), respectively, in a cell-free chemical system. In addition, a marked
increase in mitochondrial reactive oxygen species (ROS) was observed in STZ-induced diabetic cells; this increase was attenuated
by KIOM-4 treatment. Mitochondrial manganese superoxide dismutase (Mn SOD) activity and protein expression were down-
regulated by STZ treatment and up-regulated by KIOM-4 treatment. In addition, NF-E2 related factor 2 (Nrf2), a transcription
factor for Mn SOD, was up-regulated by KIOM-4. KIOM-4 prevented STZ-induced mitochondrial lipid peroxidation, protein
carbonyl and DNA modiﬁcation. Moreover, KIOM-4 treatment restored the loss of mitochondrial membrane potential (Δψ)
that was induced by STZ treatment, and inhibited the translocation of cytochrome c from the mitochondria to the cytosol. In
addition, KIOM-4 treatment elevated the level of ATP, succinate dehydrogenase activity and insulin level, which were reduced by
STZ treatment. These results suggest that KIOM-4 exhibits a protective eﬀect through its antioxidant eﬀect and the attenuation of
mitochondrial dysfunction in STZ-induced diabetic cells.
1.Introduction
Mitochondria have gained importance in our understanding
of diabetes because mitochondrial function is required for
normal glucose-stimulated insulin release from pancreatic
β-cells [1]. Mitochondria continuously generate superoxide
radicalasabyproductofelectrontransport [2,3].The super-
oxide anion is quickly dismutated to hydrogen peroxide by
mitochondrial manganese superoxide dismutase (Mn SOD)
[4], and hydrogen peroxide is subsequently converted to
water and oxygen by mitochondrial catalase and glutathione
peroxidase [5]. Mitochondria not only produce reactive
oxygen species (ROS) but are also the primary target of
ROS attacks. Impaired mitochondrial function can lead to
increased ROS generation and may increase oxidative stress
if the antioxidant defense mechanisms of the cells are over-
whelmed [6, 7]. Increased oxidative stress by mitochondrial
dysfunction is considered a causal link between elevated
glucose and the major biochemical pathways postulated to
be involved in the pathogenesis of diabetes and diabetic
complications [8, 9]. Streptozotocin (STZ) [N-(methyl nitro
carbamoyl)-d-glucosamine] has been used to act as diabeto-
genic agent due to its ability to destruct pancreatic β-cells
via the formation of ROS [10, 11]. It has been reported that
production of mitochondrial ROS increased in STZ-treated
rat, and mitochondrial lipid peroxidation was observed in
pancreatic tissue, suggesting STZ-induced mitochondrial
oxidative stress [12]. Thus, antioxidant therapy may be a
promising therapeutic approach for controlling diabetes or
diabetic complications.2 Evidence-Based Complementary and Alternative Medicine
KIOM-4 is a combination of extracts obtained from
Magnolia oﬃcinalis, Pueraria lobata, Glycyrrhiza uralensis
and Euphorbia pekinensis. M. oﬃcinalis exhibits antimu-
tagenic, hepato-protective, neuro-protective, antiinﬂamma-
tory and antimicrobial activities [13–18]. P. lobata has
antimutagenic, antidiabetic and antioxidant eﬀects [19–
21]. G. uralensis has been documented as having detoxi-
ﬁcation, antioxidant, antiulcer, antiinﬂammatory, antiviral,
antiatherogenic, anticarcinogenic eﬀects and cytoprotective
eﬀect of hepatocyte against hepatotoxicity [22–24]. E.
pekinensis has antiviral and cytotoxic activities [25, 26]. We
recently demonstrated that KIOM-4 exhibits cytoprotective
eﬀectsagainstSTZ-inducedoxidativestress damageinβ-cells
via the activation of catalase and heme oxygenase-1 [27, 28].
This study was undertaken to investigate the protective
eﬀect of KIOM-4 and its mechanism against STZ-induced
oxidative mitochondrial damage in pancreatic β-cells.
2.Methods
2.1. Preparation of KIOM-4. The cortex of M. oﬃcinalis,
and radixes of P. lobata, G. uralensis and E. pekinensis were
collected from the Gamsuk province in China, and identiﬁed
by Prof. J.H. Kim of the Division of Life Science, Daejeon
University, Korea. All voucher specimens were deposited at
the herbarium of the Department of Herbal Pharmaceutical
Development, Korea Institute of Oriental Medicine (No.
1240, 2, 7 and 207, resp.). An equal amount of Magnoliae
cortex, and radixes of Puerariae, Glycyrrhizae and Euphoriae
was mixed, pulverized and extracted in 80% ethanol for one
weekatroomtemperature,concentratedusingarotary evap-
orator and lyophilized. The entire procedure was repeated
four times. KIOM-4 was dissolved in dimethyl sulfoxide
(DMSO), the ﬁnal concentration of which did not exceed
0.1%.
2.2. Reagents. STZ was purchased from Calbiochem (San
Diego, CA). Dihydrorhodamin 123 (DHR 123) and JC-1
(5,5 ,6,6 -tetrachloro-1,1 ,3,3 -tetraethyl-benzimidazolcar-
bocyanine iodide) were purchased from Molecular Probes
(Eugene, OR). Cytochrome c (H-104), Nrf2 (C-20)
antibodies were purchased from the Santa Cruz Bio-
technology (Santa Cruz, CA). The Mn SOD polyclonal
antibody was purchased from the Stressgen Corporation
(Victoria, Canada). 5, 5-dimethyl-1-pyrroline-N-oxide
(DMPO)and [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium] bromide (MTT) were purchased from the Sigma
Chemical Company (St. Louis, MO).
2.3. Cell Culture and Treatments. RINm5F rat pancreatic β-
cells were maintained at 37◦Ci na ni n c u b a t o rw i t hah u m i d -
iﬁed atmosphere of 5% CO2, and cultured in RPMI-1640
medium containing 10% heat-inactivated fetal calf serum,
streptomycin (100μgml −1) and penicillin (100unitsml−1).
Cells were seeded on to a culture plate at a concentration of
1 × 105 cells ml−1, and at 16h after plating were treated with
KIOM-4 at 50 μgml −1.A f t e r1h ,1 0m MS T Zw a sa d d e dt o
the plate.
2.4. Detection of Superoxide Radical. Superoxide radicals
were produced by reaction of the xanthine/xanthine oxidase
system and reacted with spin trap DMPO. The DMPO–
·OOH adducts were detected using electron spin resonance
(ESR) spectroscopy [29]. The ESR spectrum was recorded
2.5min after mixing in a phosphate buﬀer solution (pH 7.4)
with 6 M DMPO 20 μl, xanthine oxidase (0.25Uml−1)2 0μl,
xanthine (5mM) 20 μl and KIOM-4 (ﬁnal 50μgml −1)2 0μl
using JES-FA ESR spectrometer (JEOL, Tokyo, Japan).
2.5. Detection of Hydroxyl Radical. Hydroxyl radicals were
generated by Fenton reaction. Hydroxyl radicals reacted with
DMPO and the resultant DMPO–OH adducts were detected
using an ESR spectrometer [29]. The ESR spectrum was
recorded 2.5min after mixing in a phosphate buﬀer solution
(pH 7.4) with 0.2ml of 0.3M DMPO, 0.2ml of 10mM
FeSO4, 0.2ml of 10mM H2O2 and KIOM-4 using ESR
spectrometer.
2.6. Mitochondrial ROS Measurement. The RINm5F cells
were seeded on to a 96-well plate at 2 × 104 cells/well. At
16h after plating, the cells were treated with KIOM-4 at
50μgml −1, and 1h later 10mM STZ was added to the plate.
The cells were incubated for an additional 30min at 37◦C.
After addition of 20μM of DHR 123 solution for 10min,
the ﬂuorescence was detected using a Perkin Elmer LS-5B
spectroﬂuorometer and ﬂow cytometer (Becton Dickinson,
Mountain View, CA). For image analysis of the generation
of mitochondrial ROS, the cells were seeded on a cover-
slip loaded six-well plate at 2 × 105 cells/well. At 16h after
plating, the cells were treated with KIOM-4, and 1h later
10mM STZ was added to the plate. After changing the
media, 20μM of DHR 123 was added to each well and
the plate was incubated for an additional 30min at 37◦C.
After washing with PBS, the stained cells were mounted
onto a microscope slide in mounting medium (DAKO,
Carpinteria, CA). Images were collected using the Laser
Scanning Microscope 5 PASCAL program (Carl Zeiss, Jena,
Germany) on a confocal microscope.
2.7. Cellular Mitochondrial Fractionation. Mitochondrial
fractions were isolated by diﬀerential centrifugation using
the mitochondria isolation kit (Active-Motif, Carlsbad, CA).
2.8. Measurement of Mn SOD Activity. The RINm5F cells
were seeded on to a culture dish at a concentration of 1 ×
105 cells ml−1, and at 16h after plating were treated with
KIOM-4 at 50μgml −1.After1h,10mMSTZwasaddedto
the plate, which was incubated for a further 24h. The har-
vested cells were suspended in 10mM phosphate buﬀer (pH
7.5) and then lysed on ice by sonicating twice for 15 s. Triton
X-100 (1%) was then added to the lysates and incubated for
10min on ice. The lysates were clariﬁed, by centrifugation
at 5000g for 30min at 4◦C, and the protein content
of the supernatant was determined. Fifty micrograms of
protein was added to 500mM phosphate buﬀer (pH 10.2),
1mM potassium cyanide (inhibitor of Cu Zn SOD) andEvidence-Based Complementary and Alternative Medicine 3
1mM epinephrine. Epinephrine rapidly undergoes auto-
oxidationatpH10toproduceadrenochrome,apink-colored
product, which was assayed at 480nm using a UV/VIS
spectrophotometer in the kinetic mode. Mn SOD inhibits
theauto-oxidationofepinephrine. The rateofinhibitionwas
monitored at 480nm and the amount of enzyme required to
produce 50% inhibition was deﬁned as one unit of enzyme
activity, and the Mn SOD activity was expressed as units/mg
protein [30].
2.9. Western Blot. Aliquots of the lysates (40μgo fp r o t e i n )
were boiled for 5min and electrophoresed on a 10%
SDS-polyacrylamide gel. Blots in the gels were transferred
onto nitrocellulose membranes (Bio-Rad, Hercules, CA).
The nitrocellulose membrane was incubated with primary
antibodies (1:1000) at 4◦Co v e r n i g h t .S e c o n d a r ya n t i b o d y
horseradish peroxidase conjugates (1:5000) (Pierce, Rock-
land, IL)were added,and incubatedatroom temperaturefor
1h, and exposed to X-ray ﬁlm. Protein bands were detected
using an enhanced chemiluminescence western blotting
detection kit (Amersham, Little Chalfont, Buckinghamshire,
UK).
2.10. Lipid Peroxidation Assay. Lipid peroxidation was
assayed by determination of 8-isoprostane levels [31]i nt h e
culturemedium, by use of a commercial enzyme immunoas-
say kit (Cayman Chemical, Ann Arbor, MI) according to the
manufacturer’s instructions.
2.11. Protein Carbonyl Formation. The amount of protein
carbonyl formation was determined using an Oxiselect
proteincarbonyl ELISAkit purchased from Cell Biolabs(San
Diego, CA) according to the manufacturer’s instructions.
2.12. 8-Hydroxyl-2 -deoxyguanosine Assay. The amount of
8-hydroxyl-2 -deoxyguanosine (8-OHdG) was determined
using a Bioxytech 8-OHdG-ELISA Kit purchased from
OXIS Health Products (Portland, OR) according to the
manufacturer’s instructions.
2.13. Mitochondrial Membrane Potential Analysis. Mito-
chondrial membrane potential (Δψ) was analyzed using JC-
1,alipophiliccationicﬂuorescencedye.Cellswere harvested,
and after changing the media, JC-1 was added to each
well and incubated for an additional 30min at 37◦C. After
washing with PBS, the stained cells were assayed using
ﬂow cytometer. For image analysis of mitochondrial Δψ,
the stained cells were mounted onto microscope slide in
mounting medium. Microscopic imageswere collected using
the Laser Scanning Microscope 5 PASCAL program on
confocal microscope [32].
2.14. Quantiﬁcation of Cellular ATP Levels. The mitochon-
drial function was evaluated by measuring the cellular
adenosine triphosphate (ATP) production in cells. The
cells were harvested and washed twice with PBS. The
harvested cells were then lysed on ice for 30min in 200μl
of lysis buﬀer [25mM Tris (pH 7.8), 270mM sucrose,
1mM EDTA] by sonicating three times for 15s and cen-
trifuged at 4◦C for 10min at 16000g. Supernatants were
collected from the lysates and ATP content was assayed
usingaluciferase/luciferinATPdeterminationkit(Molecular
Probes, Eugene, OR) [33].
2.15. Mitochondrial Succinate Dehydrogenase Activity. To
evaluate mitochondrial metabolic activity, mitochondrial
succinate dehydrogenase activity was estimated by the MTT
assay [34].The cellswere treated with KIOM-4at50μgml −1.
After 1h, 10mM of STZ, and the mixture was incubated
for 24h. Fifty microliters of the [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium]bromide(MTT)stocksolution
(2mgml−1) was then added into each well to attain a total
reaction volume of 200μl. After incubating for 4h, the plate
was centrifuged at 800g for 5min and the supernatants were
aspirated. The formazan crystals in each well were dissolved
in 150μl of dimethylsulfoxide and read at A540 on a scanning
multi-well spectrophotometer [35].
2.16. Measurements of Insulin Levels. The cells were treated
with KIOM-4 at 50μgml −1,a n d1hl a t e r1 0 m MS T Zw a s
added to the plate, and the mixture was incubated for 24h.
The amount of insulin was determined by using an ELISA
rat speciﬁc insulin enzyme immunoassay kit(Spi-Bio,Massy,
France).
2.17. Statistical Analysis. All the measurements were made
in triplicate and all values are represented as the mean ±
standard error of the mean (SEM). Data were subjected to
an analysis of the variance (ANOVA) using the Tukey test
to analyze the diﬀerence. A P-value of <.05 was considered
signiﬁcant.
3.Results
3.1. Radical Scavenging Activity of KIOM-4 in a Cell-Free
System. Our previous result showed that the intracellular
ROS scavenging activity of KIOM-4 was 48, 55 and 66% at
concentrations of 10, 50 and 100μgml −1, respectively [24].
And KIOM-4 at concentrations of 100μgml −1 showed some
cytotoxicity (data not shown). Therefore, we determined to
choose 50μgml −1 as optimal dose for further study. The
radical scavenging eﬀects of KIOM-4 on superoxide radicals
and hydroxyl radicals were measured. Superoxide radicals
produced by the xanthine/xanthine oxidase system and the
hydroxyl radicals generated by the Fenton reaction (FeSO4 +
H2O2) in a cell-free system were detected by ESR spectrome-
try.TheESRresultsrevealednoclearsignalinthecontroland
the 50μgml −1 of KIOM-4; however, the superoxide radical
signal increased to 646 in the xanthine/xanthine oxidase
system. KIOM-4 treatment decreased the superoxide radical
signal to 209 (Figure 1(a)). In addition, the hydroxyl radical
signal increasedto2809intheFeSO4 +H 2O2 system.KIOM-
4 treatment decreased the hydroxyl radical signal to 386
(Figure 1(b)).4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: The eﬀect of KIOM-4 on cell-free generation of
superoxide and hydroxyl radicals. (a) Superoxide radicals were
generated by xanthine/xanthine oxidase and reacted with DMPO;
the resultant DMPO-OOH adducts were detected using an ESR
spectrometer. (b) Hydroxyl radicals were generated by the Fenton
reaction (H2O2/FeSO4) and reacted with DMPO; the resultant
DMPO-OH adducts were detected using an ESR spectrometer.
3.2. Reduction of Mitochondrial ROS by KIOM-4 Treatment.
The ﬂuorescence dye DHR 123 was used to detect mito-
chondrial ROS in cells after STZ treatment. The ﬂuorescence
spectrometric data revealed that STZ treatment increased
the level of mitochondrial ROS compared with control.
However, treatment with KIOM-4 at 50μgml −1 attenuated
the STZ-induced ROS increase (Figure 2(a)). In addition,
ﬂow cytometry revealed a ﬂuorescence intensity of 106
for ROS in STZ-treated cells with KIOM-4 at 50μgml −1,
compared with a ﬂuorescence intensity of 533 in STZ-
treated cells (Figure 2(b)). Confocal microscopy revealed
that KIOM-4 reduced the red ﬂuorescence intensity of
STZ-induced mitochondrial ROS (Figure 2(c)). These data
suggest that KIOM-4 had mitochondrial ROS scavenging
properties.
3.3. Induction of Mn SOD and Its Transcription Factor by
KIOM-4 Treatment. M nS O Da c t sa saﬁ r s td e f e n s es y s t e m
to protect mitochondria and other cellular components
as it scavenges superoxide anion in the mitochondrial
matrix [36]. As shown in Figure 3(a),M nS O Da c t i v i t yw a s
30Umg−1 protein with 50μgml −1 of KIOM-4, compared
with 26Umg−1 protein in the control. STZ treatment
decreased the SOD activity to 12Umg−1 protein; however,
treatment with KIOM-4 increased this activity to 20Umg−1
protein. In addition, western blot data revealed that STZ
treatment decreased the expression of Mn SOD compared
with control. KIOM-4 treatment at 50μgml −1 increased the
Mn SOD level attenuated by STZ treatment (Figure 3(b)).
Mn SOD has an antioxidant response element (ARE)
sequence in its promoter region. Nrf2 is an important
transcription factor that regulates ARE-driven Mn SOD
expression. Nuclear Nrf2 expression was decreased by STZ
treatment; however, KIOM-4 treatment cells increased the
nuclear Nrf2 expression (Figure 3(c)). These data suggest
that KIOM-4 exhibited induction of Mn SOD via activation
of Nrf2.
3.4. Protection of Damaged Mitochondrial Components by
KIOM-4 Treatment. The level of 8-isoprostan, a marker
of lipid peroxidation, is increased to 230pgml−1 in cells
exposed to STZ, compared with 159pgml−1 in control cells.
KIOM-4, however, decreased this level to 161pgml−1 in
STZ-treated cells (Figure 4(a)). The mitochondrial protein
carbonyl content, which is marker of protein modiﬁcation
[37],increased signiﬁcantly after STZtreatment, and KIOM-
4 prevented the STZ-induced protein carbonyl formation
(Figure 4(b)). STZ treatment increased the amount of 8-
OHdG, which is marker of base modiﬁcation in DNA [38],
to 2006pgml−1 compared with 247pgml−1 in control cells,
and KIOM-4 decreased 8-OHdG to 777pgml−1 in STZ-
treated cells (Figure 4(c)). These data suggest that KIOM-
4 provides protection against STZ-induced mitochondrial
damages.
3.5. Recovery of Disrupted Mitochondrial Δψ and Its Related
Protein by KIOM-4 Treatment. The mitochondrial Δψ,
which is a marker of mitochondrial membrane integrity, was
detected using ﬂowcytometry and confocal microscopy after
staining with the ﬂuorescence dye JC-1. The ﬂow cytometric
data showed that the STZ treatment resulted in the loss of
Δψ, as substantiated by an increase in ﬂuorescence (FL-1)
with JC-1. KIOM-4 treatment blocked the loss of Δψ in
STZ-treated cells. The ﬂuorescence intensity was 301 value
in STZ-treated cells with 50μgml −1 of KIOM-4, compared
with a ﬂuorescence intensity of 586 in STZ-treated cells
(Figure 5(a)). In addition, the confocal microscopy data
showed that control cells and cells treated with KIOM-4
only exhibited strong red ﬂuorescence in the mitochondria
after JC-1 staining, indicating that mitochondrial Δψ was
in the polarized state (Figure 5(b), left panel). However,
STZ treatment resulted in decreased red ﬂuorescence in the
mitochondria and increased green ﬂuorescence, suggesting
that STZ treatment disrupted the mitochondrial Δψ to a
depolarized state. KIOM-4 treatment decreased the green
ﬂuorescence in STZ-treated cells (Figure 5(b),r i g h tp a n e l ) ,
indicating that KIOM-4 inhibited the loss of Δψ in response
to STZ treatment. The pore opening induces the loss of Δψ,
which in turn induces the release of cytochrome c from
the mitochondria and most commonly leads to apoptotic
cell death [39]. KIOM-4 inhibited the STZ-induced release
of cytochrome c from the mitochondria into the cytosolEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: The eﬀect of KIOM-4 on STZ-induced mitochondrial ROS generation. The cells were treated with KIOM-4 at 50μgml −1.A f t e r
1h, 10mM of STZ was added to the plate. After an additional 30min, the mitochondrial ROS were detected by spectroﬂuorometry (a)
and ﬂow cytometry (b) after DHR 123 treatment. FI indicates the ﬂuorescence intensity of DHR 123.(c) The representative confocal images
illustratetheincreaseinred ﬂuorescenceintensityofDHR 123produced by ROS inSTZ-treated cells scomparedwiththatincontrolandthe
lowered ﬂuorescence intensity in STZ-treated cells with KIOM-4 (original magniﬁcation ×400). The measurements were made in triplicate
and the values were expressed as means ± SEM. Asterisk represents signiﬁcantly diﬀerent from control cells (P < .05) and double asterisk
represent signiﬁcantly diﬀerent from STZ-treated cells (P < .05).
(Figure 5(c)). These results suggest that KIOM-4 protected
against STZ-damage to mitochondrial Δψ.
3.6. Enhancement of Decreased Intracellular ATP Level, Mito-
chondrial Enzymes, and Insulin Secretion by KIOM-4 Treat-
ment. Mitochondrial injury is followed by the depletion of
intracellular ATP and mitochondrial enzymes. As shown in
Figure 6(a), STZ treatment reduced the ATP level compared
with that in control cells; however, KIOM-4 treatment
recovered the ATP level in STZ-treated cells. Mitochondrial
succinate dehydrogenase activity was decreased in STZ-
treated cells; however, KIOM-4 treatment of STZ-treated6 Evidence-Based Complementary and Alternative Medicine
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cells enhanced this activity (Figure 6(b)). Furthermore, STZ
decreasedtheinsulinlevelofRINm5F,which secretesinsulin,
however, KIOM-4 treatment of STZ-treated cells enhanced
insulin secretion (Figure 6(c)). These results suggest that
KIOM-4 attenuates mitochondrial dysfunction in STZ-
induced diabetic cells.
4.Discussion
Mitochondrial radical production and consequent oxida-
tive damage contribute to the progressive and patho-
physiological conditions of diabetes. It has been suggested
thatmitochondrialROSinducedbyhighglucosemightcause
the pathogenesis of diabetes mellitus and its complications
through modiﬁcation of various mitochondrial events [40].
Consequently, therapeutic strategies to decrease ROS pro-
duction or to intercept these ROS should be explored [41].
Numerous studies have reported that antioxidant treatment,
which targets oxidative stress, may help prevent or delay
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the development of diabetes and its complications [42, 43].
In this context, the possible anti-diabetic eﬀects of KIOM-
4 on the oxidative mitochondrial damage induced by STZ
treatment in pancreatic β-cells were elucidated. In this
study, KIOM-4 exhibited signiﬁcant ROS radical scavenging
activity against superoxide and hydroxyl radicals. Moreover,
KIOM-4 attenuated the STZ-induced increase in mitochon-
drial ROS. Mn SOD is located in the mitochondrial matrix8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: The eﬀect of KIOM-4 on intracellular ATP level,
mitochondrial enzyme, and insulin level. (a) ATP content was
assayed using a luciferase/luciferin ATP determination kit. (b)
Mitochondrial succinate dehydrogenase activity was estimated by
the MTT assay. (c) The amount of insulin was determined by using
an ELISA rat speciﬁc insulin enzyme immunoassay kit. Asterisk
represent signiﬁcantly diﬀerent from control cells (P < .05) and
double asterisk represent signiﬁcantly diﬀerent from STZ-treated
cells (P < .05).
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Mitochondrial damage
Diabetes
KIOM-4 Mn SOD
Mitochondria dysfunction
KIOM-4
Figure 7: A proposed pathway for protective eﬀect of KIOM-4
againstSTZ-induced mitochondrialoxidativestress inpancreatic β-
cells via its antioxidant eﬀects.
and is the primary SOD isoform that dismutates superoxide
anions generated by the mitochondrial respiratory chain
[44]. Pancreatic cells contain relatively low levels of antiox-
idant enzymes, making these cells more vulnerable to oxida-
tive stress [42, 45]. A signiﬁcant imbalance between ROS
production and endogenous Mn SOD has been conﬁrmed
by the reduced activity and protein expression of Mn SOD
in STZ-treated cells. In diabetes, decreased Mn SOD activity
promotes the damage to cellular components such as lipid,
protein and DNA [46]. Treatment with KIOM-4 restored the
MnSODactivitydecreasedbySTZ.Inaddition,ourprevious
study suggested that KIOM-4 exhibited cytoprotectiveeﬀects
against STZ-induced oxidative stress damage in β-cells
via the activation of catalase and heme oxygenase-1 [27,
28]. Meanwhile, Nrf2 is able to activate the antioxidant-
responsive element (ARE)-dependent gene expression in
order to maintain cellular redox homeostasis [47]. Nrf2
is an important transcription factor that regulates ARE-
driven expression of antioxidant genes, including Mn SOD.
Nuclear Nrf2 expression was decreased by STZ treatment;
however, KIOM-4 treatment recovered the nuclear Nrf2
expression. The components in the mitochondrial matrix
are highly susceptible to an oxidative environment [48].
KIOM-4 prevented the STZ-induced mitochondrial lipid
peroxidation, protein carbonyl and DNA modiﬁcation. In
general, mitochondrial DNA is more vulnerable to oxidativeEvidence-Based Complementary and Alternative Medicine 9
stress, and the subsequent damage is more extensive than
that in nuclear DNA due to the lack of protective histones
and low repair mechanisms [45, 46]. Elevated oxidative
stress can increase the membrane permeability of the
mitochondria by opening pores in the inner mitochondrial
membrane, and can lead to the loss of Δψ [49]. The loss
of mitochondrial Δψ can cause the release of cytochrome
c and the activation of the apoptotic pathway [50]. Indeed,
STZ treatment disrupted the mitochondrial Δψ and resulted
in the release of mitochondrial cytochrome c to cytosol.
However, KIOM-4 prevented the sequential mitochondrial
damageprocessinducedbySTZtreatment.Theelevatedlevel
of mitochondrial ROS generated by STZ acts as a powerful
oxidant and causes damage to mitochondrial respiratory
chain complexes. As mitochondria are the major producers
ofATP, mitochondrial dysfunction also leadsto reduced ATP
levels [51]. Depletion of ATP content was observed in STZ-
treated cells as a consequence of impaired mitochondrial
respiratory chain activity. Succinate dehydrogenase is a
mitochondrial TCA cycle enzyme and its activity is mainly
regulated by ATP [52]. KIOM-4 treatment restored the ATP
content and the succinate dehydrogenase activity, which
were both reduced by STZ treatment. It has been reported
that STZ treatment can increase mitochondrial ROS in rat
pancreatic tissue, and the mitochondrial oxidative stress
reduces insulin secretion by pancreatic β-cells [12, 53].
KIOM-4 signiﬁcantly increased insulin content decreased by
STZ treatment.
Hence,theseresultssuggestthatKIOM-4protectsagainst
ROS-mediated mitochondrial dysfunction in diabetic pan-
creatic β-cells by scavenging ROS and inducing mitochon-
drial antioxidant enzymes (Figure 7).
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